UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063108
Receipt number R000072235
Scientific Title Investigation of Morphological Changes in Corneal Sensory Nerves and Their Effects on Corneal Perception and Pain in Dry Eye
Date of disclosure of the study information 2026/09/30
Last modified on 2026/09/30 01:02:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of Morphological Changes in Corneal Sensory Nerves and Their Effects on Corneal Perception and Pain in Dry Eye

Acronym

Investigation of Morphological Changes in Corneal Sensory Nerves and Their Effects on Corneal Perception and Pain in Dry Eye

Scientific Title

Investigation of Morphological Changes in Corneal Sensory Nerves and Their Effects on Corneal Perception and Pain in Dry Eye

Scientific Title:Acronym

Investigation of Morphological Changes in Corneal Sensory Nerves and Their Effects on Corneal Perception and Pain in Dry Eye

Region

Japan


Condition

Condition

dry eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this cross-sectional study is to evaluate corneal sensory nerve morphology, corneal sensation and pain, tear film break-up time (TFBUT), and other subjective and objective findings related to dry eye disease in three populations: healthy adults, asymptomatic individuals with shortened TFBUT (TFBUT-shortened subjects), and patients diagnosed with dry eye disease.
Through comparative assessment across these groups, the study aims to exploratorily identify characteristic morphological changes in corneal sensory nerves associated with the progression of dry eye disease and to clarify the influence of these morphological changes on corneal sensory function and pain perception.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Differences in corneal sensory nerve morphological parameters among classified groups

Key secondary outcomes

Differences in subjective symptom scores, tear osmolarity, wavefront aberrations, TFBUT, keratoconjunctival epithelial damage scores, corneal sensation/pain, and tear volume among classified groups
Correlations between corneal sensory nerve morphological parameters and each index


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Subjects aged 18 years or older at the time of providing informed consent
Subjects who are capable of providing written informed consent of their own free will

Key exclusion criteria

Subjects with comorbid or past ocular diseases other than dry eye that affect the ocular surface, corneal sensation/pain, or nerve morphology evaluation
Subjects with a history of corneal surgery, cataract surgery, LASIK, corneal transplantation, or other ocular surgeries
Subjects with comorbid or past diabetes mellitus or other systemic diseases affecting the nervous system
Subjects who are otherwise judged inappropriate for participation by the principal investigator or sub-investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Taiichiro
Middle name
Last name Chikama

Organization

Hiroshima University

Division name

Department of Ophthalmology and Visual Science, Hiroshima University Graduate School of Biomedical and Health Sciences

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima-shi, Hiroshima

TEL

082-257-5247

Email

yurie0429@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name yurie
Middle name
Last name shimizu

Organization

Hiroshima University

Division name

Department of Ophthalmology and Visual Science

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima-shi, Hiroshima

TEL

082-257-5247

Homepage URL


Email

yurie0429@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Senju Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Epidemiological Research Ethics Committee of Hiroshima University

Address

1-2-3 Kasumi, Minami-ku, Hiroshima-shi, Hiroshima

Tel

082-257-1520

Email

yurie0429@hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 30 Day

Date of IRB


Anticipated trial start date

2027 Year 01 Month 01 Day

Last follow-up date

2027 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a single-center, cross-sectional observational study evaluating corneal nerve morphology, corneal sensation, and ocular pain in dry eye patients, asymptomatic subjects with shortened TFBUT, and healthy controls.


Management information

Registered date

2026 Year 09 Month 30 Day

Last modified on

2026 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072235